v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities    
Net loss $ (4,430,629) $ (1,231,791)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities    
Accretion of discount on notes payable 847,259   
Amortization of debt issuance costs 102,556   
Change in allowance for inventory obsolescence 76,001   
Change in allowance for sales returns (59,518) (251,565)
Change in allowance for uncollectible accounts 18,324 (15,755)
Depreciation and amortization 285,456 19,940
Gain on warrant revaluation (1,702,841)   
Warrants issued for services 24,951   
Share-based compensation expense 253,792 468,830
Changes in operating assets and liabilities    
Accounts receivable 125,537 1,241,399
Inventories (1,180,148) 331,507
Prepaid expenses and other current assets (1,340,306) (94,309)
Accounts payable 83,580 525,729
Accrued expenses and other current liabilities 847,719 113,456
Deferred revenue (50,745) (198,574)
Other (44,510) (9,047)
Net cash (used in) provided by operating activities (6,143,522) 899,820
Cash flows from investing activities    
Decrease in restricted cash 22,118   
Patent renewal costs (9,500)   
Cash acquired in connection with acquisitions 150,398   
Purchase of property and equipment (130,823)   
Net cash provided by investing activities 32,193   
Cash flows from financing activities    
Capital contribution from Infusion Brands International 31,161   
Funds borrowed from affliated entities    370,134
Net payments made on accounts receivable factoring arrangement (404,655) (1,427,536)
Principal payments on notes payable (45,321)   
Proceeds from senior secured note payable 8,406,833   
Net cash provided by (used in) financing activities 7,988,018 (1,057,402)
Net decrease in cash 1,876,689 (157,582)
Cash at beginning of year 91,397 288,779
Cash at end of year 1,968,086 131,197
Supplemental Cash Flow Information    
Interest paid in cash 1,526,183 169,269
Income taxes paid in cash      
Non Cash Investing and Financing Activities    
Anti-dilutive shares issued 712   
Capital contribution from Infusion Brands International 10,181,201   
Common shares issued in connection with merger 5,997,476   
Insurance premiums financed through note payable 138,139   
Warrants issued with notes payable 2,407,930   
Reclassification of accrued interest to principal balance of debt 211,562   
Debt issuance costs withheld from debt proceeds $ 441,000